Safety issues related to the administration of ribavirin
- PMID: 12150196
- DOI: 10.1097/00006454-200205000-00037
Safety issues related to the administration of ribavirin
Similar articles
-
Ribavirin administration via scavenger vacuum systems in the treatment of respiratory syncytial virus (RSV).J Pediatr Nurs. 1994 Feb;9(1):51-4. J Pediatr Nurs. 1994. PMID: 8201541 No abstract available.
-
[Respiratory syncytial virus infections and ribavirin: the controversy continues].Arch Pediatr. 1998 Feb;5(2):107-10. doi: 10.1016/s0929-693x(97)86822-4. Arch Pediatr. 1998. PMID: 10223129 Review. French. No abstract available.
-
In that case: response.J Bioeth Inq. 2005;2(1):55. J Bioeth Inq. 2005. PMID: 16025625 No abstract available.
-
In that case: response.J Bioeth Inq. 2005;2(1):53-4. J Bioeth Inq. 2005. PMID: 16025623 No abstract available.
-
Therapy of respiratory syncytial virus infection.Pediatr Infect Dis J. 2000 Aug;19(8):786-90; discussion 802-4, 811-3. doi: 10.1097/00006454-200008000-00032. Pediatr Infect Dis J. 2000. PMID: 10959759 Review. No abstract available.
Cited by
-
Managing pediatric hepatitis C: current and emerging treatment options.Ther Clin Risk Manag. 2009 Jun;5(3):651-60. doi: 10.2147/tcrm.s5078. Epub 2009 Aug 20. Ther Clin Risk Manag. 2009. PMID: 19707281 Free PMC article.
-
Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.J Virol. 2004 Jun;78(11):5773-83. doi: 10.1128/JVI.78.11.5773-5783.2004. J Virol. 2004. PMID: 15140975 Free PMC article.
-
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.Oncogene. 2019 Mar;38(13):2241-2262. doi: 10.1038/s41388-018-0567-7. Epub 2018 Nov 26. Oncogene. 2019. PMID: 30478448 Free PMC article.
-
Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome.Front Pediatr. 2016 Nov 24;4:128. doi: 10.3389/fped.2016.00128. eCollection 2016. Front Pediatr. 2016. PMID: 27933286 Free PMC article. Review.
-
Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.J Virol. 2021 Sep 27;95(20):e0120521. doi: 10.1128/JVI.01205-21. Epub 2021 Aug 11. J Virol. 2021. PMID: 34379500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical